)
)
89Bio Investor Relations Material
Latest events
Status Update
89Bio
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from 89Bio Inc
Access all reports
89Bio Inc is a clinical-stage biopharmaceutical company focused to the development and commercialization of therapies aimed at treating liver and cardio-metabolic diseases. The company is building a pipeline that includes biologic and small molecule treatments, focusing on addressing unmet medical needs in these therapeutic areas. The company is headquartered in San Francisco, California, and its shares are listed on the NASDAQ under the symbol ETNB.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
ETNB
Country
🇺🇸 United States